Pfizer to take over 40% stake in Brazilian OTC firm Teuto
Under the contract, Pfizer will make an upfront payment of $240m and Teuto will be eligible to receive a performance-based milestone payment. Pfizer has an option to acquire
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
The software integration supports academic and commercial researchers studying genes affects and individuals response to drug treatments. According to the companies, joint customers will have a clear workflow